Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,334Revenue $M284Net Margin (%)2.1Altman Z-Score-2.1
Enterprise Value $M1,208EPS $0.0Operating Margin %14.9Piotroski F-Score6
P/E(ttm)373Beneish M-Score-1.4Pre-tax Margin (%)2.0Higher ROA y-yY
Price/Book37.310-y EBITDA Growth Rate %--Quick Ratio3.6Cash flow > EarningsN
Price/Sales4.65-y EBITDA Growth Rate %-28.7Current Ratio3.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)1.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)19.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M132ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NKTR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
NKTRJoel Greenblatt 2015-06-30 Buy 0.14%$9.52 - $13.84
$ 10.08-12%New holding1,363,927
NKTRFirst Eagle Investment 2011-12-31 Sold Out -0.003%$4.22 - $5.62
$ 10.08106%Sold Out0
NKTRFirst Eagle Investment 2011-09-30 Buy $4.98 - $7.65
$ 10.0869%New holding125,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NKTR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

NKTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Labrucherie Gil MSVP & General Counsel 2015-08-13Sell33,333$10.89-7.44view
ROBIN HOWARD WPresident & CEO 2015-08-13Sell58,333$10.89-7.44view
Nicholson JohnSVP & CFO 2015-08-12Sell319,884$10.78-6.49view
ROBIN HOWARD WPresident & CEO 2015-07-14Sell58,334$11.78-14.43view
Labrucherie Gil MSVP & General Counsel 2015-07-14Sell33,334$11.78-14.43view
WANG SUSANDirector 2015-06-29Sell30,000$12.7-20.63view
CHESS ROBERTDirector 2015-06-19Sell15,000$11.81-14.65view
Lingnau LutzDirector 2015-06-15Sell25,000$11.15-9.6view
KUEBLER CHRISTOPHER ADirector 2015-01-13Sell15,000$16-37view
CHESS ROBERTDirector 2014-12-29Sell29,500$15.34-34.29view

Quarterly/Annual Reports about NKTR:

    News about NKTR:

    Articles On GuruFocus.com
    Weekly Guru Bargains Highlights: AKAM, NKTR, LOGI, FFIV, LCC Apr 16 2011 
    Weekly Guru Bargains Highlights: AMSC, LOGI, NKTR, DAL, AIG Apr 09 2011 
    Four Guru Stocks near New Lows: FBN, HOME, NKTR, PETS Feb 07 2011 
    MannKind: Deja Vu for the FDA and Afrezza Dec 29 2010 
    Nektar Therapeutics Reports Operating Results (10-Q) Nov 04 2010 
    Nektar Therapeutics Reports Operating Results (10-Q) Jul 29 2010 
    Nektar Therapeutics Reports Operating Results (10-Q) May 06 2010 
    cooldecency99 note on NKTR May 01 2010 
    Small-Cap Biotech Stocks: Why This Sector Is Set for a Huge Year Jan 06 2010 
    Nektar Therapeutics Reports Operating Results (10-Q) Nov 05 2009 

    More From Other Websites
    NEKTAR THERAPEUTICS Financials Aug 14 2015
    10-Q for Nektar Therapeutics Aug 09 2015
    Nektar Q2 Loss Wider-than-Expected, Outlook Maintained - Analyst Blog Aug 06 2015
    R. Scott Greer Joins Inogen Board of Directors Aug 06 2015
    NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report Aug 06 2015
    Edited Transcript of NKTR earnings conference call or presentation 5-Aug-15 9:00pm GMT Aug 05 2015
    Nektar Therapeutics Earnings Call scheduled for 5:00 pm ET today Aug 05 2015
    NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 05 2015
    Nektar Therapeutics Reports Financial Results for the Second Quarter of 2015 Aug 05 2015
    Q2 2015 Nektar Therapeutics Earnings Release - After Market Close Aug 05 2015
    Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After... Jul 29 2015
    Baxalta & Nektar Reveal Full Data from Hemophilia Study - Analyst Blog Jul 17 2015
    NEKTAR THERAPEUTICS Files SEC form 8-K, Other Events Jul 16 2015
    Baxalta's BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention... Jul 16 2015
    Mid-Morning Market Update: Markets Open Lower; Lennar Beats Q2 Estimates Jun 24 2015
    Columbia Pipeline to Join the S&P 500; Other Changes to S&P MidCap 400 & S&P SmallCap 600 Jun 24 2015
    Biotech bargain bin Jun 19 2015
    NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 17 2015
    Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for... Jun 02 2015
    bluebird bio Inc (BLUE), Nektar Therapeutics (NKTR) Among Billionaire Stan Druckenmiller’s Top... May 28 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)